Dx dialogues: stigma surrounding LAI use for schizophrenia and the importance of patient education
Ragy Girgis, MD, talks about the stigma surrounding LAI use for schizophrenia, and how we can educate our patients about these medicines.
Up Next
Dx dialogues: identifying patients who might benefit from an LAI for schizophrenia
Dx dialogues: pharmacologic advances for the treatment and management of schizophrenia
Dx dialogues: the challenges of treating tardive dyskinesia the "old-fashioned way"
Dx dialogues: why early intervention is critical in managing tardive dyskinesia
Dx dialogues: VMAT2 inhibitors and future treatments for tardive dyskinesia
Dx dialogues: novel approaches in development for the treatment of AD
Dx dialogues: recent advancements and implementation strategies in opioid use disorder treatment
Dx dialogues: considerations when deciding whether to initiate pharmacologic interventions for patients with AD
Mental health awareness: how to discuss medication
Caring for patients with schizophrenia and other psychiatric disorders
